With our strong R&D focus, competency to generate intellectual property and extensive experience in development and manufacturing of modified release formulations, we enjoy the trust of customers in more than ten countries in the Middle-East, CIS, Latin America, Africa and South-East Asia.
Newly Developed Products
Dimethyl Fumarate Pellets 30% & 55%- To Treat Multiple Sclerosis
Blended Pellets Of TamsulosinHCl&Dutasteride Pellets – To Treat BPH
Services Offered
Extensive Formulation development assistance including
- API Characterization - Pre-formulation & Formulation - Prototype construction - Analytical Method Development and Validation - Process Optimization - Stability Studies and Bioequivalence Studies
Customize drug-release profiles/non infringing compositions and processes.